MARKET

BASI

BASI

Bioanalyticl Sys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.57
-0.14
-2.45%
After Hours: 5.70 +0.13 +2.33% 16:39 02/21 EST
OPEN
5.71
PREV CLOSE
5.71
HIGH
5.71
LOW
5.00
VOLUME
67.39K
TURNOVER
--
52 WEEK HIGH
6.50
52 WEEK LOW
1.430
MARKET CAP
60.26M
P/E (TTM)
-27.5743
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BASI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

BASI News

More
  • Richard Johnson Is The Independent Director of Bioanalytical Systems, Inc. (NASDAQ:BASI) And They Just Spent US$93k On Shares
  • Simply Wall St. · 1d ago
  • Bioanalytical Systems Q1 EPS $(0.13) Down From $(0.01) YoY, Sales $12.92M Up From $8.625M YoY
  • Benzinga · 02/14 13:35
  • BASi Releases Earnings for First Quarter of Fiscal 2020
  • GlobeNewswire · 02/14 13:33
  • Inotiv Launches Website for Newly Unified Contract Research Services
  • GlobeNewswire · 02/12 14:18

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About BASI

Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.
More

Webull offers kinds of Bioanalytical Systems, Inc. stock information, including NASDAQ:BASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BASI stock news, and many more online research tools to help you make informed decisions.